ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Zealand Pharma AS (PK)

Zealand Pharma AS (PK) (ZLDPF)

97.8213
0.00
(0.00%)
Closed January 13 4:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
97.8213
Bid
97.65
Ask
103.64
Volume
280
0.00 Day's Range 0.00
60.82 52 Week Range 141.742
Market Cap
Previous Close
97.8213
Open
-
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
1,681
Shares Outstanding
51,283,851
Dividend Yield
-
PE Ratio
-7.13
Earnings Per Share (EPS)
-13.72
Revenue
358.77M
Net Profit
-703.74M

About Zealand Pharma AS (PK)

Zealand Pharma A/S was founded in 1998 and is a biotechnology company focused on the discovery, design and development of innovative peptide-based medicines. We intend to be a leader in specialty medicines focusing on metabolic and gastrointestinal diseases and other specialty disease areas with sig... Zealand Pharma A/S was founded in 1998 and is a biotechnology company focused on the discovery, design and development of innovative peptide-based medicines. We intend to be a leader in specialty medicines focusing on metabolic and gastrointestinal diseases and other specialty disease areas with significant unmet medical needs. Zealand has a portfolio of medicines and product candidates under license collaborations with Sanofi and Boehringer Ingelheim. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Soborg, Dnk
Founded
-
Zealand Pharma AS (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker ZLDPF. The last closing price for Zealand Pharma AS (PK) was $97.82. Over the last year, Zealand Pharma AS (PK) shares have traded in a share price range of $ 60.82 to $ 141.742.

Zealand Pharma AS (PK) currently has 51,283,851 shares outstanding. The market capitalization of Zealand Pharma AS (PK) is $5.02 billion. Zealand Pharma AS (PK) has a price to earnings ratio (PE ratio) of -7.13.

ZLDPF Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.79130.81552097289597.0397.8496.32113997.40649306CS
4-15.0287-13.3174124945112.85114.7295.51139103.61712018CS
12-18.9787-16.2488869863116.812693.581681107.50920685CS
26-40.7727-29.4188060089138.594141.74293.581322115.89547239CS
5236.571359.70824489861.25141.74260.821966104.63400744CS
15674.7713324.38741865523.05141.74211.14147092.12484831CS
26062.9113180.2099684934.91141.74211.14140887.23267058CS

ZLDPF - Frequently Asked Questions (FAQ)

What is the current Zealand Pharma AS (PK) share price?
The current share price of Zealand Pharma AS (PK) is $ 97.8213
How many Zealand Pharma AS (PK) shares are in issue?
Zealand Pharma AS (PK) has 51,283,851 shares in issue
What is the market cap of Zealand Pharma AS (PK)?
The market capitalisation of Zealand Pharma AS (PK) is USD 5.02B
What is the 1 year trading range for Zealand Pharma AS (PK) share price?
Zealand Pharma AS (PK) has traded in the range of $ 60.82 to $ 141.742 during the past year
What is the PE ratio of Zealand Pharma AS (PK)?
The price to earnings ratio of Zealand Pharma AS (PK) is -7.13
What is the cash to sales ratio of Zealand Pharma AS (PK)?
The cash to sales ratio of Zealand Pharma AS (PK) is 13.98
What is the reporting currency for Zealand Pharma AS (PK)?
Zealand Pharma AS (PK) reports financial results in DKK
What is the latest annual turnover for Zealand Pharma AS (PK)?
The latest annual turnover of Zealand Pharma AS (PK) is DKK 358.77M
What is the latest annual profit for Zealand Pharma AS (PK)?
The latest annual profit of Zealand Pharma AS (PK) is DKK -703.74M
What is the registered address of Zealand Pharma AS (PK)?
The registered address for Zealand Pharma AS (PK) is SYDMARKEN 11, SOBORG, DK-2600
What is the Zealand Pharma AS (PK) website address?
The website address for Zealand Pharma AS (PK) is www.zealandpharma.com
Which industry sector does Zealand Pharma AS (PK) operate in?
Zealand Pharma AS (PK) operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CRGPCalissio Resources Group Inc (CE)
$ 0.0004
(39,900.00%)
20k
SMMESmartMetric Inc (PK)
$ 0.0001
(9,900.00%)
1.25M
NEOMNeoMedia Technologies Inc (CE)
$ 0.0001
(9,900.00%)
534.97k
RRGIReality Racing Inc (CE)
$ 0.0001
(9,900.00%)
209k
ELIQQElectriq Power Holdings Inc (CE)
$ 0.0001
(9,900.00%)
290
IBKKFImining Technologies Inc (CE)
$ 0.000001
(-100.00%)
100
EGIOQEdgio Inc (CE)
$ 0.000001
(-99.99%)
905
CYBFCyberfort Software Inc (CE)
$ 0.000001
(-99.88%)
20k
CHMJDWaverunner Capital Inc
 0.0045
(-99.40%)
106
CCTLCoin Citadel (PK)
$ 0.000001
(-99.00%)
108k
HMBLHUMBL Inc (PK)
$ 0.0009
(0.00%)
359.72M
GRLFGreen Leaf Innovations Inc (PK)
$ 0.00015
(50.00%)
194.9M
AITXArtificial Intelligence Technology Solutions Inc (PK)
$ 0.00375
(-1.32%)
188.36M
TSOITherapeutic Solutions International Inc (PK)
$ 0.0002
(-33.33%)
168.26M
PHILPHI Group Inc (PK)
$ 0.00025
(-16.67%)
129.87M

ZLDPF Discussion

View Posts
Trading2retire Trading2retire 8 years ago
PR Release - FDA approval - Type II Diabetes.
👍️0
stocktrademan stocktrademan 9 years ago
$ZLDPF recent news/filings

bullish

## source: finance.yahoo.com

Mon, 14 Sep 2015 12:00:00 GMT ~ Sanofi Reports Positive Top-Line Results in Second Pivotal LixiLan Phase III Study

[PR Newswire] - PARIS, Sept. 14, 2015 /PRNewswire/ -- Sanofi announced today that the LixiLan-L Phase III clinical trial met its primary endpoint in patients with type 2 diabetes treated with insulin glargine with or without metformin. The fixed-ratio combination of insulin glargine 100 Units/mL and lixisenatide, a GLP-1 receptor agonist, demonstrated statistically superior reduction in HbA1c (average blood glucose over the previous three months) compared with insulin glargine 100 Units/mL. Overall, the fixed-ratio combination had a safety profile reflecting those of insulin glargine 100 Units/mL and lixisenatide.

read full: http://finance.yahoo.com/news/sanofi-reports-positive-top-line-120000569.html
*********************************************************

Wed, 29 Jul 2015 11:00:00 GMT ~ Sanofi Announces that First LixiLan Phase III Study Met Primary Endpoint

[PR Newswire] - PARIS, July 29, 2015 /PRNewswire/ -- Sanofi announced today that the LixiLan-O Phase III clinical trial met its primary objective in patients with type 2 diabetes treated with metformin. The fixed-ratio combination of insulin glargine 100 units/mL and lixisenatide, a GLP-1 RA, demonstrated statistically superior reduction in HbA1c (average blood glucose over the previous three months) compared with lixisenatide and compared with insulin glargine 100 units/mL. Overall, the fixed-ratio combination had a safety profile reflecting those of lixisenatide and insulin glargine 100 units/mL.

read full: http://finance.yahoo.com/news/sanofi-announces-first-lixilan-phase-110000971.html
*********************************************************

$ZLDPF charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$ZLDPF company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/ZLDPF/company-info
Ticker: $ZLDPF
OTC Market Place: OTC Pink Current
CIK code: 0001573728
Company name: Zealand Pharma A/S
Incorporated In:


$ZLDPF share structure

## source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available

$ZLDPF extra dd links

Company name: Zealand Pharma A/S
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=ZLDPF+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=ZLDPF+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=ZLDPF+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/ZLDPF/news - http://finance.yahoo.com/q/h?s=ZLDPF+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/ZLDPF/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/ZLDPF/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=ZLDPF+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/ZLDPF
DTCC (dtcc.com): http://search2.dtcc.com/?q=Zealand+Pharma+A%2FS&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Zealand+Pharma+A%2FS
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Zealand+Pharma+A%2FS&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/ZLDPF
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001573728&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/ZLDPF/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/ZLDPF/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=ZLDPF&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=ZLDPF
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/ZLDPF/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=ZLDPF+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=ZLDPF+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=ZLDPF
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=ZLDPF
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=ZLDPF+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/ZLDPF/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=ZLDPF+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/ZLDPF.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=ZLDPF
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/ZLDPF/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/ZLDPF
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/ZLDPF
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/ZLDPF:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=ZLDPF
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=ZLDPF



$ZLDPF DD Notes ~ http://www.ddnotesmaker.com/ZLDPF
👍️0
stocktrademan stocktrademan 10 years ago
$ZLDPF recent news/filings

bullish

## source: finance.yahoo.com

no recent news found
*********************************************************

$ZLDPF charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$ZLDPF company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/ZLDPF/company-info
Ticker: $ZLDPF
OTC Market Place: Grey Market
CIK code: not found
Company name: Zealand Pharma A/S
Incorporated In:

Business Description:

$ZLDPF share structure

## source: otcmarkets.com

Market Value: $412,355,476 a/o Jun 10, 2015
Shares Outstanding: 22,870,520 a/o Dec 18, 2011
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available

$ZLDPF extra dd links

Company name: Zealand Pharma A/S
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=ZLDPF+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=ZLDPF+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=ZLDPF+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/ZLDPF/news - http://finance.yahoo.com/q/h?s=ZLDPF+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/ZLDPF/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/ZLDPF/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=ZLDPF+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/ZLDPF
DTCC (dtcc.com): http://search2.dtcc.com/?q=Zealand+Pharma+A%2FS&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Zealand+Pharma+A%2FS
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Zealand+Pharma+A%2FS&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/ZLDPF
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/ZLDPF/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/ZLDPF/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=ZLDPF&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=ZLDPF
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/ZLDPF/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=ZLDPF+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=ZLDPF+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=ZLDPF
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=ZLDPF
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=ZLDPF+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/ZLDPF/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=ZLDPF+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/ZLDPF.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=ZLDPF
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/ZLDPF/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/ZLDPF/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/ZLDPF
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/ZLDPF
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/ZLDPF:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=ZLDPF
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=ZLDPF



$ZLDPF DD Notes ~ http://www.ddnotesmaker.com/ZLDPF
👍️0